(Q31893425)

English

Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

author name string

Tsunoda S

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Ishikawa T

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Watanabe M

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Kamada H

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Yamamoto Y

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Tsutsumi Y

6

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Hirano T

7

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Mayumi T

8

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

181-188

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Phase I study of recombinant human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

IgG1 plasmacytosis in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Therapeutic antibody fragments with prolonged in vivo half-lives

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Definition of a Composite Binding Site for gp130 in Human Interleukin-6

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Involvement of the Arg179 in the active site of human IL-6

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02508.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02508.X

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31893425&oldid=1595338022"